Indoco Remedies Limited (INDOCO) — Announcement Announcement
Indoco Remedies announced that its Baddi Plant III facility in Himachal Pradesh received EU GMP certification from the German Health Authority (Berlin) following an inspection conducted between April 22 and April 27, 2026. The certification confirms compliance with EC Directive manufacturing standards, reinforcing the company's quality credentials for global markets. This achievement strengthens Indoco's position as a regulated manufacturer with USFDA and UK-MHRA-approved facilities, supporting its export-oriented formulation business and expanding regulatory acceptance for its product portfolio across therapeutic segments.
📄 View Original Announcement (PDF)
About Indoco Remedies Limited (INDOCO)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.